v3 Template
U

UroGen Pharma Ltd.

Biotechnology / Healthcare Princeton, NJ ~320 employees
Founded
--
Employees (Est.)
~320
16 leaders known
Total Funding
$227.5M
Funding Rounds
2
Last Funding
2024-06-17

About UroGen Pharma Ltd.

UroGen Pharma is a biotechnology company dedicated to elevating treatment options for people living with urological cancers. With a focus on innovation, they aim to empower uro-oncology patients through life-changing therapies and breakthrough technologies, redefining possibilities in transformative treatments.

Products & Services

RTGel® Technology:A novel technology used in treatments to redefine possibilities for patients.
ZUSDURI™ (mitomycin) for intravesical solution:An FDA-approved treatment for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.
Jelmyto® (mitomycin) for pyelocalyceal solution:The first FDA-approved treatment using RTGel® technology, helping to redefine treatment possibilities for patients.

Specialties

Urological Cancer Treatments Uro-Oncology Innovative Drug Delivery Technologies Non-Muscle Invasive Bladder Cancer Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 107500000
MR: -
FA: approximately $107.5 million
FAN: 107500000
D: 2024-06-17
FD: 2024-06-17
5 investors
2 RT: Private Placement
T: -
FT: Private Placement
A: 120000000
MR: -
FA: 120 million
FAN: 120000000
D: 2023-07-27
FD: 2023-07-27
5 investors
Public Offering Latest
2024-06-17
$107.5M
5 investors (Pro only)
Private Placement 2023-07-27
$120.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

L

Liz Barrett

President and Chief Executive Officer

C

Chris Degnan

Chief Financial Officer

M

Marina Konorty

EVP, Research & Development and Technical Operations

D

David Lin

Chief Commercial Officer

M

Michael J. Louie

EVP, Medical Affairs and Clinical Development

J

Jim Ottinger

EVP, Regulatory Affairs and Quality

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

UroGen Pharma Ltd. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
urogen.com
Industries
Biotechnology / Healthcare
Company Size
~320 employees (est.)
Locations
Princeton, NJ
Princeton, NJ, USA
Princeton, New Jersey +2 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro